"Securing sustainable access to innovation through strategy, evidence, and trusted relationships."

Mikael is an experienced and commercially driven leader in the Life Science sector with more than 25 years of expertise in Market Access, Pricing, Public Affairs, and Sales. He combines strategic clarity with analytical depth and a strong understanding of healthcare systems to successfully drive reimbursement strategies, value communication, and evidence generation in complex and highly regulated environments. With a background including senior roles at AstraZeneca, he has led cross-functional initiatives that secure sustainable access to innovative treatments while balancing commercial objectives and societal value. Mikael is recognized for his ability to build long-term, trust-based relationships with authorities, policymakers, and healthcare decision-makers, translating clinical and economic data into compelling and actionable narratives. He brings a structured yet pragmatic leadership style, fostering collaboration across functions and markets. Mikael is passionate about improving patient access and ensuring that innovation is matched with affordability and system sustainability.